Bank Of America Corp Day One Biopharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 192,194 shares of DAWN stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,194

Previous 177,666 8.18%

Holding current value

$2.62 Million

Previous $2.45 Million 9.35%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $184,796 - $232,883	14,528 Added 8.18%	192,194 $2.68 Million
Q2 2024 Aug 14, 2024	BUY	$12.03 - $17.69 $602,426 - $885,862	50,077 Added 39.25%	177,666 $2.45 Million
Q1 2024 May 15, 2024	SELL	$13.56 - $17.46 $437,920 - $563,870	-32,295 Reduced 20.2%	127,589 $2.11 Million
Q4 2023 Feb 14, 2024	SELL	$9.68 - $15.37 $518,731 - $823,647	-53,588 Reduced 25.1%	159,884 $2.33 Million
Q2 2023 Aug 14, 2023	SELL	$11.74 - $14.47 $236,185 - $291,107	-20,118 Reduced 8.61%	213,472 $2.55 Million
Q1 2023 May 12, 2023	BUY	$12.75 - $23.41 $1.39 Million - $2.55 Million	109,117 Added 87.66%	233,590 $3.12 Million
Q4 2022 Feb 10, 2023	SELL	$18.77 - $22.0 $595,609 - $698,104	-31,732 Reduced 20.31%	124,473 $2.68 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $2.08 Million - $3.36 Million	126,498 Added 425.82%	156,205 $3.13 Million
Q2 2022 Aug 12, 2022	BUY	$5.72 - $17.9 $136,462 - $427,040	23,857 Added 407.81%	29,707 $531,000
Q1 2022 May 16, 2022	BUY	$9.12 - $17.47 $1,504 - $2,882	165 Added 2.9%	5,850 $58,000
Q4 2021 Feb 08, 2022	BUY	$15.65 - $26.33 $81,395 - $136,942	5,201 Added 1074.59%	5,685 $96,000
Q3 2021 Nov 15, 2021	SELL	$20.0 - $27.92 $4,320 - $6,030	-216 Reduced 30.86%	484 $11,000
Q2 2021 Sep 13, 2021	BUY	$19.0 - $23.69 $13,300 - $16,583	700 New	700 $16,000

Others Institutions Holding DAWN

# of Institutions

178

Shares Held

84M

Call Options Held

144K

Put Options Held

218K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Day One Biopharmaceuticals, Inc. Transaction History